Search results
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 3 hours agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous ...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 6 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
The Income Investor's Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
InvestorPlace· 3 days agoThe most obvious reason investors should buy high-yield dividend stocks is that they provide income....
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 2 days agoAbbVie: A top dividend growth stock AbbVie is a powerhouse dividend payer. Apart from its superb yield of 3.87%, the company has also ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 3 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
3 Stocks to Buy for Huge Income
Motley Fool via Yahoo Finance· 6 days agoToday, we will be looking at three dividend stocks that pay huge dividends, all with yields above 5%, one of which is Pfizer (NYSE: PFE ...
Pfizer Inc. (NYSE:PFE) – Experts See The Stock A Different Way Today – Marketing Sentinel
Marketing Sentinel· 2 days agoAnalyst projections state that PFE is forecast to be at a low of $20 and a high of $141.39. Pfizer Inc. (PFE) estimates and forecasts Pfizer Inc...but the ...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 2 days agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
